(LXS) LANXESS Aktiengesellschaft - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0005470405

LXS: Chemicals, Additives, Intermediates, Flavors, Fragrances, Pigments

LANXESS Aktiengesellschaft, a global leader in specialty chemicals, operates with a rich history dating back to 1863. Headquartered in Cologne, Germany, the company was spun off from Bayer in 2004, emerging as an independent entity with a strong focus on innovation and sustainability. Listed on the XETRA exchange under the ticker LXS, LANXESS is structured into three core segments: Consumer Protection, Specialty Additives, and Advanced Intermediates, each catering to diverse industrial needs.

The Consumer Protection segment excels in material protection products, including water purification technologies and disinfectants, crucial for public health. Specialty Additives provides solutions for industries like automotive and electronics, enhancing product performance. Advanced Intermediates focuses on chemicals essential for agriculture and manufacturing, underscoring LANXESSs role in global supply chains.

With a market capitalization of 2289.04M EUR, LANXESS offers attractive valuations, reflected in its P/B ratio of 0.50. Its forward P/E of 14.58 indicates growth potential, aligning with its strategic focus on ESG practices and innovation. This positioning makes LANXESS a compelling option for investors seeking exposure to specialty chemicals with a strong emphasis on sustainability and global market presence.

Additional Sources for LXS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

LXS Stock Overview

Market Cap in USD 2,219m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

LXS Stock Ratings

Growth Rating -37.2
Fundamental -20.6
Dividend Rating 6.42
Rel. Strength -0.49
Analysts -
Fair Price Momentum 21.76 EUR
Fair Price DCF 41.74 EUR

LXS Dividends

Dividend Yield 12m 0.80%
Yield on Cost 5y 0.52%
Annual Growth 5y -36.25%
Payout Consistency 88.9%

LXS Growth Ratios

Growth Correlation 3m -18.2%
Growth Correlation 12m 31.1%
Growth Correlation 5y -84.5%
CAGR 5y -8.31%
CAGR/Max DD 5y -0.12
Sharpe Ratio 12m -0.79
Alpha -9.76
Beta 0.819
Volatility 54.86%
Current Volume 463.5k
Average Volume 20d 495.7k
What is the price of LXS stocks?
As of April 24, 2025, the stock is trading at EUR 24.88 with a total of 463,475 shares traded.
Over the past week, the price has changed by +4.01%, over one month by -17.31%, over three months by -0.44% and over the past year by -6.38%.
Is LANXESS Aktiengesellschaft a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, LANXESS Aktiengesellschaft is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -20.64 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LXS as of April 2025 is 21.76. This means that LXS is currently overvalued and has a potential downside of -12.54%.
Is LXS a buy, sell or hold?
LANXESS Aktiengesellschaft has no consensus analysts rating.
What are the forecast for LXS stock price target?
According to ValueRays Forecast Model, LXS LANXESS Aktiengesellschaft will be worth about 23.5 in April 2026. The stock is currently trading at 24.88. This means that the stock has a potential downside of -5.55%.
Issuer Forecast Upside
Wallstreet Target Price 28.5 14.4%
Analysts Target Price - -
ValueRay Target Price 23.5 -5.5%